StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-0.08%)

Close on Nov 18, 2026Market cap $383.32KP/E –Yield –

VivoSim Labs operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

VivoSim Labs's operating cash flow for the twelve months ending Jun 30, 2026 was -$10.10M. For fiscal 2026 it was -$10.83M. The highest annual figure on record is -$820.00K in fiscal 2010.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$10.83M–
FY2025Mar 31, 2025-$9.46M–
FY2024Mar 31, 2024-$14.65M–
FY2023Mar 31, 2023-$12.41M–
FY2022Mar 31, 2022-$8.45M–
FY2021Mar 31, 2021-$13.32M–
FY2020Mar 31, 2020-$14.88M–
FY2019Mar 31, 2019-$20.38M–
FY2018Mar 31, 2018-$28.86M–
FY2017Mar 31, 2017-$29.19M–
FY2016Mar 31, 2016-$29.37M–
FY2015Mar 31, 2015-$19.60M–
FY2012Dec 31, 2012-$9.69M–
FY2011Dec 31, 2011-$1.91M–
FY2010Dec 31, 2010-$820.00K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$3.21M–
Q4 FY2026CQ1 2026Mar 31, 2026-$2.24M–
Q3 FY2026CQ4 2025Dec 31, 2025-$2.27M–
Q2 FY2026CQ3 2025Sep 30, 2025-$2.38M–
Q1 FY2026CQ2 2025Jun 30, 2025-$3.94M–
Q4 FY2025CQ1 2025Mar 31, 2025-$2.04M–
Q3 FY2025CQ4 2024Dec 31, 2024-$1.80M–
Q2 FY2025CQ3 2024Sep 30, 2024-$2.64M–
Q1 FY2025CQ2 2024Jun 30, 2024-$2.98M–
Q4 FY2024CQ1 2024Mar 31, 2024-$2.67M–
Q3 FY2024CQ4 2023Dec 31, 2023-$3.52M–
Q2 FY2024CQ3 2023Sep 30, 2023-$3.15M–
Q1 FY2024CQ2 2023Jun 30, 2023-$5.31M–
Q4 FY2023CQ1 2023Mar 31, 2023-$4.73M–
Q3 FY2023CQ4 2022Dec 31, 2022-$3.04M–
Q2 FY2023CQ3 2022Sep 30, 2022-$2.22M–
Q1 FY2023CQ2 2022Jun 30, 2022-$2.41M–
Q4 FY2022CQ1 2022Mar 31, 2022-$1.54M–
Q3 FY2022CQ4 2021Dec 31, 2021-$3.36M–
Q2 FY2022CQ3 2021Sep 30, 2021-$2.14M–
Q1 FY2022CQ2 2021Jun 30, 2021-$1.41M–
Q4 FY2021CQ1 2021Mar 31, 2021-$2.11M–
Q3 FY2021CQ4 2020Dec 31, 2020-$1.49M–
Q2 FY2021CQ3 2020Sep 30, 2020-$7.15M–
Q1 FY2021CQ2 2020Jun 30, 2020-$2.57M–
Q4 FY2020CQ1 2020Mar 31, 2020-$3.21M–
Q3 FY2020CQ4 2019Dec 31, 2019-$583.00K–
Q2 FY2020CQ3 2019Sep 30, 2019-$5.16M–
Q1 FY2020CQ2 2019Jun 30, 2019-$5.94M–
Q4 FY2019CQ1 2019Mar 31, 2019-$5.08M–
Q3 FY2019CQ4 2018Dec 31, 2018-$3.95M–
Q2 FY2019CQ3 2018Sep 30, 2018-$4.32M–
Q1 FY2019CQ2 2018Jun 30, 2018-$7.02M–
Q4 FY2018CQ1 2018Mar 31, 2018-$5.61M–
Q3 FY2018CQ4 2017Dec 31, 2017-$6.44M–
Q2 FY2018CQ3 2017Sep 30, 2017-$6.15M–
Q1 FY2018CQ2 2017Jun 30, 2017-$10.65M–
Q4 FY2017CQ1 2017Mar 31, 2017-$7.23M–
Q3 FY2017CQ4 2016Dec 31, 2016-$7.05M–
Q2 FY2017CQ3 2016Sep 30, 2016-$6.37M–

More VivoSim Labs figures

See a number that looks wrong?